Annual Short Term Debt
$8.52 M
+$2.55 M+42.68%
31 December 2023
Summary:
Foghorn Therapeutics annual short term debt is currently $8.52 million, with the most recent change of +$2.55 million (+42.68%) on 31 December 2023. During the last 3 years, it has risen by +$4.54 million (+113.97%). FHTX annual short term debt is now at all-time high.FHTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$8.77 M
+$395.00 K+4.72%
30 September 2024
Summary:
Foghorn Therapeutics quarterly short term debt is currently $8.77 million, with the most recent change of +$395.00 thousand (+4.72%) on 30 September 2024. Over the past year, it has increased by +$398.00 thousand (+4.75%). FHTX quarterly short term debt is now at all-time high.FHTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FHTX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.7% | +4.8% |
| 3 y3 years | +114.0% | +25.4% |
| 5 y5 years | +100.0% | - |
FHTX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +114.0% | at high | +54.7% |
| 5 y | 5 years | at high | at high | +120.3% | |
| alltime | all time | at high | at high | +120.3% |
Foghorn Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.77 M(+4.7%) |
| June 2024 | - | $8.38 M(-3.4%) |
| Mar 2024 | - | $8.67 M(+1.8%) |
| Dec 2023 | $8.52 M(+42.7%) | $8.52 M(+1.7%) |
| Sept 2023 | - | $8.37 M(+9.2%) |
| June 2023 | - | $7.67 M(+20.9%) |
| Mar 2023 | - | $6.35 M(+6.3%) |
| Dec 2022 | $5.97 M | $5.97 M(-10.5%) |
| Sept 2022 | - | $6.67 M(+17.7%) |
| June 2022 | - | $5.67 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.10 M(-12.7%) |
| Dec 2021 | $6.99 M(+75.7%) | $6.99 M(+0.0%) |
| Sept 2021 | - | $6.99 M(+0.6%) |
| June 2021 | - | $6.95 M(+18.0%) |
| Mar 2021 | - | $5.89 M(+47.9%) |
| Dec 2020 | $3.98 M(-27.8%) | $3.98 M(-34.5%) |
| Sept 2020 | - | $6.08 M(+13.3%) |
| June 2020 | - | $5.37 M(-2.6%) |
| Dec 2019 | $5.51 M(>+9900.0%) | $5.51 M |
| Dec 2018 | $0.00 | - |
FAQ
- What is Foghorn Therapeutics annual short term debt?
- What is the all time high annual short term debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual short term debt year-on-year change?
- What is Foghorn Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly short term debt year-on-year change?
What is Foghorn Therapeutics annual short term debt?
The current annual short term debt of FHTX is $8.52 M
What is the all time high annual short term debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual short term debt is $8.52 M
What is Foghorn Therapeutics annual short term debt year-on-year change?
Over the past year, FHTX annual short term debt has changed by +$2.55 M (+42.68%)
What is Foghorn Therapeutics quarterly short term debt?
The current quarterly short term debt of FHTX is $8.77 M
What is the all time high quarterly short term debt for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly short term debt is $8.77 M
What is Foghorn Therapeutics quarterly short term debt year-on-year change?
Over the past year, FHTX quarterly short term debt has changed by +$398.00 K (+4.75%)